References
- Cherkasov A, Muratov EN, Fourches D, et al. QSAR modeling: where have you been? Where are you going to? J Med Chem. 2014;57:4977–5010. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24351051
- Zhu H, Tropsha A, Fourches D, et al. Combinatorial QSAR modeling of chemical toxicants tested against tetrahymena pyriformis. J Chem Inf Model. 2008;48:766–784.
- Alves VM, Muratov E, Fourches D, et al. Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization. Toxicol Appl Pharmacol. 2015;284:273–280.
- Zhang L, Fourches D, Sedykh A, et al. Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. J Chem Inf Model. 2013;53:475–492.
- Zakharov AV, Varlamova EV, Lagunin AA, et al. QSAR modeling and prediction of drug-drug interactions. Mol Pharm. 2016;13:545–556.
- Low Y, Uehara T, Minowa Y, et al. Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. Chem Res Toxicol. 2011;24:1251–1262. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21699217
- Sedykh A, Fourches D, Duan J, et al. Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013;30:996–1007. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23269503
- Braga RC, Alves VM, Silva MFB, et al. Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity. Mol Inform. 2015;34:698–701.
- Carlson HA, Smith RD, Damm-Ganamet KL, et al. CSAR 2014: a benchmark exercise using unpublished data from pharma. J Chem Inf Model. 2016;56:1063–1077. Available from: http://pubs.acs.org/doi/abs/10.1021/acs.jcim.5b00523
- Tetko IV, Sushko I, Pandey AK, et al. Critical assessment of QSAR models of environmental toxicity against tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J Chem Inf Model. 2008;48:1733–1746.
- Todeschini R, Consonni V. Handbook of molecular descriptors [Internet]. Todeschini R, Consonni V, editors. New York. Weinheim, Germany: Wiley-VCH Verlag GmbH; 2000. Available from: http://www.amazon.com/Handbook-Molecular-Descriptors-Roberto-Todeschini/dp/3527299130
- Doweyko AM. 3D-QSAR illusions. J Comput Aided Mol Des. 2004;18:587–596.
- Jagiello K, Grzonkowska M, Swirog M, et al. Advantages and limitations of classic and 3D QSAR approaches in nano-QSAR studies based on biological activity of fullerene derivatives. J Nanopart Res. 2016;18:256–272. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27642255
- Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc. 1988;110:5959–5967.
- Lill MA. Multi-dimensional QSAR in drug discovery. Drug Discov Today. 2007;12:1013–1017.
- Fourches D, Politi R, Tropsha A. Target-specific native/decoy pose classifier improves the accuracy of ligand ranking in the CSAR 2013 benchmark. J Chem Inf Model. 2015;55:63–71. Available from: http://pubs.acs.org/doi/abs/10.1021/ci500519w
- Mazanetz M, Laughton C, Fischer P. Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer’s disease. Molecules. 2014;19:9134–9159.
- McClendon CL, Kornev AP, Gilson MK, et al. Dynamic architecture of a protein kinase. Proc Natl Acad Sci. 2014;111:E4623–E4631.
- Hopfinger AJ, Wang S, Tokarski JS, et al. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J Am Chem Soc. 1997;119:10509–10524.
- Andrade CH, Pasqualoto KFM, Ferreira EI, et al. 4D-QSAR: perspectives in drug design. Molecules. 2010;15:3281–3294. Available from: http://www.mdpi.com/1420-3049/15/5/3281/
- Venkatarangan P, Hopfinger AJ. Prediction of ligand−receptor binding free energy by 4D-QSAR analysis: application to a set of glucose analogue inhibitors of glycogen phosphorylase. J Chem Inf Comput Sci. 1999;39:1141–1150.
- Romeiro NC, Albuquerque MG, de Alencastro RB, et al. Construction of 4D-QSAR models for use in the design of novel p38-MAPK inhibitors. J Comput Aided Mol Des. 2005;19:385–400.
- Kuz’min VE, Artemenko AG, Lozitsky VP, et al. The analysis of structure-anticancer and antiviral activity relationships for macrocyclic pyridinophanes and their analogues on the basis of 4D QSAR models (simplex representation of molecular structure). Acta Biochim Pol. 2002;49:157–168. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12136936
- Kuz’min VE, Artemenko AG, Polischuk PG, et al. Hierarchic system of QSAR models (1D–4D) on the base of simplex representation of molecular structure. J Mol Model. 2005;11:457–467. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16237516
- Santos-Filho OA, Hopfinger AJ. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of hiv-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism. J Chem Inf Model. 2006;46:345–354.
- Ash J, Fourches D. Characterizing the chemical space of ERK2 kinase inhibitors using descriptors computed from molecular dynamics trajectories. J Chem Inf Model. 2017;57:1286–1299. Available from: http://pubs.acs.org/doi/abs/10.1021/acs.jcim.7b00048
- Riniker S. Molecular dynamics fingerprints (MDFP): machine learning from MD data to predict free-energy differences. J Chem Inf Model. 2017;57:726–741. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28368113
- Hopfinger AJ, Reaka A, Venkatarangan P, et al. Construction of a virtual high throughput screen by 4D-QSAR analysis: application to a combinatorial library of glucose inhibitors of glycogen phosphorylase b. J Chem Inf Comput Sci. 1999;39:1151–1160.
- Pan D, Iyer M, Liu J, et al. Constructing optimum blood brain barrier QSAR models using a combination of 4D-molecular similarity measures and cluster analysis. J Chem Inf Comput Sci. 2004;44:2083–2098.
- Allinger NL. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem Soc. 1977;99:8127–8134.
- Wieder M, Garon A, Perricone U, et al. Common hits approach: combining pharmacophore modeling and molecular dynamics simulations. J Chem Inf Model. 2017;57:365–385.
- Dreher J, Scheiber J, Stiefl N, et al. xMaP—an interpretable alignment-free four-dimensional quantitative structure–activity relationship technique based on molecular surface properties and conformer ensembles. J Chem Inf Model. 2018;58:165–181.
- Bak A, Kozik V, Smolinski A, et al. Multidimensional (3D/4D-QSAR) probability-guided pharmacophore mapping: investigation of activity profile for a series of drug absorption promoters. RSC Adv. 2016;6:76183–76205.
- Martins JPA, Barbosa EG, Pasqualoto KFM, et al. LQTA-QSAR: a new 4D-QSAR methodology. J Chem Inf Model. 2009;49:1428–1436.
- Damale MG, Harke SN, Kalam Khan FA, et al. Recent advances in multidimensional QSAR (4D-6D): a critical review. Mini Rev Med Chem. 2014;14:35–55.
- Teófilo RF, Martins JPA, Ferreira MMC. Sorting variables by using informative vectors as a strategy for feature selection in multivariate regression. J Chemom. 2009;23:32–48.
- Vedani A, Dobler M, Zbinden P. Quasi-atomistic receptor surface models: a bridge between 3-D QSAR and receptor modeling. J Am Chem Soc. 1998;120:4471–4477.
- Vedani A, Dobler M. 5D-QSAR: the key for simulating induced fit? J Med Chem. 2002;45:2139–2149.
- Vedani A, Dobler M, Lill MA. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor †. J Med Chem. 2005;48:3700–3703.
- Polanski J. Receptor dependent multidimensional QSAR for modeling drug - receptor interactions. Curr Med Chem. 2009;16:3243–3257.
- Martin YC. Let’s not forget tautomers. J Comput Aided Mol Des. 2009;23:693–704. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2776169&tool=pmcentrez&rendertype=abstract
- Daré JK, Ramalho TC, Freitas MP. 3D perspective into MIA-QSAR: a case for anti-HCV agents. Chem Biol Drug Des. 2019;93:1096–1104. Available from: http://doi.wiley.com/10.1111/cbdd.13440
- Kuenemann MA, Fourches D. Cheminformatics analysis of dynamic WNK-inhibitor interactions. Mol Inform. 2018;37:e1700138–e1700154. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29473325
- Kuenemann MA, Spears PA, Orndorff PE, et al. In silico predicted glucose-1-phosphate uridylyltransferase (GalU) inhibitors block a key pathway required for listeria virulence. Mol Inform. 2018;37:2–7.
- Fourches D, Muratov E, Tropsha A. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model. 2010;50:1189–1204.
- Fourches D, Muratov E, Tropsha A. Trust, but verify II: a practical guide to chemogenomics data curation. J Chem Inf Model. 2016;56:1243–1252.
- Sutherland JJ, Nandigam RK, Erickson JA, et al. Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracy. J Chem Inf Model. 2007;47:2293–2302. Available from: https://pubs.acs.org/doi/10.1021/ci700253h
- Ramírez D, Caballero J. Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Molecules. 2018;23:1038. Available from: http://www.mdpi.com/1420-3049/23/5/1038
- Sherman W, Day T, Jacobson MP, et al. Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem. 2006;49:534–553.
- Yap CW. PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem. 2011;32:1466–1474. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21425294
- Todeschini R, Gramatica P. The WHIM theory: new 3D molecular descriptors for QSAR in environmental modelling. SAR QSAR Environ Res. 1997;7:89–115.
- Tropsha A. Best practices for QSAR model development, validation, and exploitation. Mol Inform. 2010;29:476–488.
- Damm-Ganamet KL, Smith RD, Dunbar JB, et al. CSAR benchmark exercise 2011–2012: evaluation of results from docking and relative ranking of blinded congeneric series. J Chem Inf Model. 2013;53:1853–1870. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3753884&tool=pmcentrez&rendertype=abstract
- Fourches D, Muratov E, Ding F, et al. Predicting binding affinity of CSAR ligands using both structure-based and ligand-based approaches. J Chem Inf Model. 2013;53:1915–1922. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23809015
- Bowers K, Chow E, Xu H, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. ACM/IEEE SC 2006 Conference, Tampa, Florida; 2006. p. 43.
- Tseng YJ, Hopfinger AJ, Esposito EX. The great descriptor melting pot: mixing descriptors for the common good of QSAR models. J Comput Aided Mol Des. 2012;26:39–43.